UAB "Via pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 114,039 |
| 38,013 |
| 10,310 |
| 8,763 |
| 2,921 |
| 51.84 |
| 7.68 |
| 95,163 |
| 79,973 |
| 221 |
| 174,915 |
| 2023 |
|---|
| 49,866 |
| 14,975 |
| -19,824 |
| -19,824 |
| -5,953 |
| 37.54 |
| -39.75 |
| 75,338 |
| 60,661 |
| 1 |
| 135,998 |
| 2024 |
|---|
| 75,983 |
| 18,996 |
| -51,473 |
| -51,473 |
| -12,868 |
| -11.79 |
| -67.74 |
| 23,865 |
| 62,021 |
| 1 |
| 85,885 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
75,983 €
52 % *
Sales per employee (€)
18,996 €27 % *
Profit before tax (€)
-51,473 €
-160 % *
Net Profit (€)
-51,473 €-160 % *
Profit per employee (€)
-12,868 €-116 % *
Total profitability (%)
-11.79 %-131.41 % *
Net profitability (%)
-67.74 %-70.42 % *
Equity (€)
23,865 €-68 % *
Amounts Payable And Liabilities (€)
62,021 €
2 % *
Non-current Assets (€)
1 €
0 % *
CurrentAssets (€)
85,885 €
-37 % *